- 6-thioguanine therapy in inflammatory bowel disease2004 | First Faculty of Medicine
- Does 6-thioguanine therapy represent a new promising therapeutical modality?Publication without faculty affiliation
- 6-thioguanine therapy on patients intolerant or refractory to azathioprine or 6-mercaptopurine therapyPublication without faculty affiliation
- 6-thioguanine therapy on patients intolerant or refractory to azathioprine or 6-mercaptopurine therapy (3)Publication without faculty affiliation
- 6-thioguanine therapy on patients intolerant or refractory to azathioprine or 6-mercaptopurine therapy (1)Publication without faculty affiliation
- 6-thioguanine therapy on patients intolerant or refractory to azathioprine or 6-mercaptopurine therapy (2)Publication without faculty affiliation
- A multicenter assesment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine2005 | First Faculty of Medicine
- A multicenter assesment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine2005 | Faculty of Physical Education and Sport
- 6-Thioguanine treatment in inflammatory bowel disease: A critical appraisal by a European 6-TG working party2006 | First Faculty of Medicine
- 6-Thioguanine treatment in inflammatory bowel disease: A critical appraisal by a European 6-TG working party2006 | Faculty of Physical Education and Sport
- Prediction of Thiopurine Metabolite Levels Based on Haematological and Biochemical Parameters2019 | Second Faculty of Medicine
- Does 6-thioguanine therapy represent a new promising therapeutic modality2004 | First Faculty of Medicine
- Is It Useful to Monitor Thiopurine Metabolites in Pediatric Patients with Crohn's Disease on Combination Therapy? A Multicenter Prospective Observational Study2021 | First Faculty of Medicine, Second Faculty of Medicine
- Thiopurine methyltransferase activity, 6-methylmercaptopurin and 6-thioguanin levels in patients with IBD: the influence on adverse events of azathioprine therapyPublication without faculty affiliation
- Thiopurine methyltransferase activity, 6methylmercaptopurine and 6-thioguanine levels in patients with IBD: the influence on adverse events of azathioprine therapyPublication without faculty affiliation
- Steady-state of azathioprine during initiation treatment of pediatric inflammatory bowel disease2010 | Faculty of Medicine in Hradec Králové
- The 6-thioguanine (6-TG) online survey platform: an international, multi-centric approach to summarize clinical data collected during the use 6-TG in patients with inflammatory bowel disease (IBD)Publication without faculty affiliation
- Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis2011 | First Faculty of Medicine
- Are changes in the blood count clinically useful marker of azathioprine dose?2020 | Third Faculty of Medicine
- Pharmacokinetics of azathioprine during the first weeks of treatment of Crohn´s disease and ulcerative colitis in children and adolescents +12009 | Faculty of Medicine in Hradec Králové
- Pharmacokinetics of azathioprine during the first weeks of treatment of Crohn´s disease and ulcerative colitis in children and adolescents2009 | First Faculty of Medicine
- Azathioprine in the therapy of paediatric inflammatory bowel disease - part II: pharmacodynamics, pharmacokinetics, and the possibilities of measuring its metabolites in clinical practice2021 | Second Faculty of Medicine
- Thiopurine-induced toxicity is associated with dysfunction variant of the human molybdenum cofactor sulfurase gene (xanthinuria type II)2018 | First Faculty of Medicine
